ATE192435T1 - Verbindungen mit analgetischem und lokalanesthetischem effekt - Google Patents

Verbindungen mit analgetischem und lokalanesthetischem effekt

Info

Publication number
ATE192435T1
ATE192435T1 AT95910029T AT95910029T ATE192435T1 AT E192435 T1 ATE192435 T1 AT E192435T1 AT 95910029 T AT95910029 T AT 95910029T AT 95910029 T AT95910029 T AT 95910029T AT E192435 T1 ATE192435 T1 AT E192435T1
Authority
AT
Austria
Prior art keywords
compounds
analgesic
aesthetic effects
local aesthetic
local
Prior art date
Application number
AT95910029T
Other languages
English (en)
Inventor
Anna-Lena Ask
Lars-Inge Olsson
Rune Sandberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Application granted granted Critical
Publication of ATE192435T1 publication Critical patent/ATE192435T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Finger-Pressure Massage (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT95910029T 1994-02-11 1995-02-03 Verbindungen mit analgetischem und lokalanesthetischem effekt ATE192435T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9400447A SE9400447D0 (sv) 1994-02-11 1994-02-11 New compounds
PCT/SE1995/000106 WO1995021821A1 (en) 1994-02-11 1995-02-03 New compounds with analgesic and local anaesthetic effect

Publications (1)

Publication Number Publication Date
ATE192435T1 true ATE192435T1 (de) 2000-05-15

Family

ID=20392881

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95910029T ATE192435T1 (de) 1994-02-11 1995-02-03 Verbindungen mit analgetischem und lokalanesthetischem effekt

Country Status (31)

Country Link
US (2) US5756520A (de)
EP (1) EP0743940B1 (de)
JP (1) JPH09508904A (de)
CN (1) CN1067989C (de)
AT (1) ATE192435T1 (de)
AU (1) AU686760B2 (de)
BR (1) BR9506748A (de)
CA (1) CA2181068A1 (de)
CZ (1) CZ286753B6 (de)
DE (1) DE69516671T2 (de)
DK (1) DK0743940T3 (de)
EE (1) EE03252B1 (de)
ES (1) ES2148493T3 (de)
FI (1) FI963128L (de)
GR (1) GR3033999T3 (de)
HR (1) HRP950414B1 (de)
HU (1) HU216734B (de)
IL (1) IL112374A (de)
IS (1) IS1771B (de)
MX (1) MX9603092A (de)
MY (1) MY130166A (de)
NO (1) NO306718B1 (de)
NZ (1) NZ281355A (de)
PL (1) PL180212B1 (de)
PT (1) PT743940E (de)
RU (1) RU2145599C1 (de)
SE (1) SE9400447D0 (de)
SK (1) SK281931B6 (de)
TW (1) TW348176B (de)
WO (1) WO1995021821A1 (de)
ZA (1) ZA95709B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9523526D0 (en) * 1995-11-17 1996-01-17 Zeneca Ltd Therapeutic compounds
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
DE19912889A1 (de) * 1999-03-23 2000-09-28 Daimler Chrysler Ag Verfahren zur Herstellung eines Ventilsitzes
US7645771B2 (en) * 2002-12-13 2010-01-12 Smithkline Beecham Corp. CCR5 antagonists as therapeutic agents
US6916833B2 (en) * 2003-03-13 2005-07-12 Hoffmann-La Roche Inc. Substituted piperidines
FR2861074B1 (fr) * 2003-10-17 2006-04-07 Sanofi Synthelabo Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
AR063275A1 (es) * 2006-10-12 2009-01-14 Epix Delaware Inc Compuestos de carboxamida, una composicion farmaceutica que los comprende y su uso en la preparacion de un medicamento para el tratamiento de enfermedades mediadas por la activacion de ccr2.
BRPI0820701A2 (pt) 2007-12-11 2015-06-16 Cytopathfinder Inc Composto de carboxamida e seu uso como agonistas do receptor de quimiocina
US8473062B2 (en) 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US9320908B2 (en) * 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism
US20100185249A1 (en) * 2009-01-22 2010-07-22 Wingeier Brett M Method and Devices for Adrenal Stimulation
EP3914246A1 (de) 2019-01-22 2021-12-01 ICM (Institut du Cerveau et de la Moelle Épinière) Lokalanästhetikum zur behandlung von neurologischen symptomen infolge von hirnfunktionsstörungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2951080A (en) * 1957-08-05 1960-08-30 Lilly Co Eli Novel phenyl-substituted piperidines
NL130088C (de) * 1960-03-14
US3850935A (en) * 1971-10-16 1974-11-26 Sumitomo Chemical Co Process for producing piperidine derivatives by degrading quaternary piperidinium salts
US4369184A (en) * 1980-01-24 1983-01-18 Janssen Pharmaceutica N.V. 1-(Cyclohexyl)-4-aryl-4-piperidinecarboxylic acid derivatives
SE8904298D0 (sv) * 1989-12-21 1989-12-21 Astra Ab New compounds
US5661162A (en) * 1992-12-14 1997-08-26 Merck Sharp & Dohme Limited 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperdines as tachykinin receptor antagonists

Also Published As

Publication number Publication date
NO963292D0 (no) 1996-08-07
PL180212B1 (pl) 2001-01-31
GR3033999T3 (en) 2000-11-30
IS1771B (is) 2001-05-28
CZ286753B6 (en) 2000-06-14
ZA95709B (en) 1995-08-11
JPH09508904A (ja) 1997-09-09
EP0743940B1 (de) 2000-05-03
HU216734B (hu) 1999-08-30
EP0743940A1 (de) 1996-11-27
HUT75641A (en) 1997-05-28
SK92896A3 (en) 1997-07-09
CN1067989C (zh) 2001-07-04
HRP950414A2 (en) 1997-10-31
AU1826995A (en) 1995-08-29
US5968953A (en) 1999-10-19
MY130166A (en) 2007-06-29
NO963292L (no) 1996-08-07
RU2145599C1 (ru) 2000-02-20
MX9603092A (es) 1997-03-29
US5756520A (en) 1998-05-26
CA2181068A1 (en) 1995-08-17
EE03252B1 (et) 2000-02-15
FI963128A7 (fi) 1996-08-09
HRP950414B1 (en) 2001-02-28
AU686760B2 (en) 1998-02-12
ES2148493T3 (es) 2000-10-16
DE69516671T2 (de) 2001-02-01
DK0743940T3 (da) 2000-08-14
SK281931B6 (sk) 2001-09-11
IL112374A0 (en) 1995-03-30
FI963128A0 (fi) 1996-08-09
PL315777A1 (en) 1996-12-09
NZ281355A (en) 1998-02-26
SE9400447D0 (sv) 1994-02-11
TW348176B (en) 1998-12-21
FI963128L (fi) 1996-08-09
CZ203296A3 (en) 1996-12-11
NO306718B1 (no) 1999-12-13
BR9506748A (pt) 1997-09-16
PT743940E (pt) 2000-08-31
CN1140448A (zh) 1997-01-15
DE69516671D1 (de) 2000-06-08
WO1995021821A1 (en) 1995-08-17
HU9602206D0 (en) 1996-10-28
IL112374A (en) 1999-12-31
IS4251A (is) 1995-08-12

Similar Documents

Publication Publication Date Title
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
MY132705A (en) Novel compounds with analgesic effect
EE200000320A (et) Uudsed ühendid
SE9704544D0 (sv) Novel compounds
SE9401728D0 (sv) New compounds II
ATE192435T1 (de) Verbindungen mit analgetischem und lokalanesthetischem effekt
LTIP1731A (en) Substituted 4-phenyl-4-piperidinecarboxamides with both local anaesthetic and analgesic effect as well as processes for their preparation
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
GEP20043225B (en) 1-Trifluoromethyl-4-Hydroxy-7- Piperidinyl-Aminomethylchroman Derivatives
LV10917A (lv) Bambuterina pielietojums lipidu saturu pazeminosu farmaceitisku kompoziciju pagatavosanai
FI930097A7 (fi) Annostusmuoto lääkeaineen antamiseksi vuorokausiterapian toteuttamista varten
YU52495A (sh) Nova jedinjenja sa analgetskim i lokalno anestetičkim dejstvom
JO1652B1 (en) New compounds for local anesthesia and a way to prepare them
JO1658B1 (en) New vehicles
SK887U (sk) Zmes liečivých rastlín na liečenie nádorových a iných ochorení
TH19526A (th) วิธีการและสารผสมสำหรับรักษาโรคตับอักเสบชนิดออโตอิมมูน
UA38697A (uk) Спосіб лікування генералізованого пародонтиту

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee